Proposed Collection: Title: Next Series of Tobacco Use Supplements to the Current Population Survey (TUSCPS). Type of information request: REINSTATEMENT WITH CHANGE of OMB 09250368, Expiration 4/30/2009. Need and Use of Information Collection: The 2010 2011 Tobacco Use Supplement to the Current Population Survey conducted by the Census Bureau will collect data from the U.S. civilian non institutionalized population on smoking, other tobacco use, and attempts at cessation; policy information such as home and workplace smoking policies; health professional advice to stop smoking; and changes in smoking no ]]> http://thefederalregister.com/d.p/2009-11-06-E9-26848 Fri, Nov 6 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-11-04-E9-26607 ]]> http://thefederalregister.com/d.p/2009-11-04-E9-26607 Wed, Nov 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-28-E9-25954

Proposed Collection: Title: A Generic Submission For Formative Research, Pretesting, and Customer Satisfaction of NCI's Communication and Education Resources. Type of Information Collection Request: REVISION. Need and Use of Information Collection: In order to carry out NCI's legislative mandate to educate and disseminate information about cancer prevention, detection, diagnosis, and treatment to a wide variety of audiences and organizations (e.g., cancer patients, their families, the general public, health providers, the media, voluntary groups, scientific and medical organizations), it is beneficial for NCI, through its ]]> http://thefederalregister.com/d.p/2009-10-28-E9-25954 Wed, Oct 28 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-22-E9-25307

Background: The National Center for Complementary and Alternative Medicine (NCCAM) was established in 1998 with the mission of exploring complementary and alternative healing practices in the context of rigorous science, training CAM researchers, and disseminating authoritative information to the public and professionals.

To date, NCCAM's efforts to rigorously study CAM, to train CAM researchers, and to communicate with the public and professionals, have been guided by NCCAM's pr ]]> http://thefederalregister.com/d.p/2009-10-22-E9-25307 Thu, Oct 22 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-16-E9-24873

Proposed Collection: Title: Evaluation of the NIAID HIV Vaccine Research Education Initiative. Type of Information Collection Request: NEW ]]> http://thefederalregister.com/d.p/2009-10-16-E9-24873 Fri, Oct 16 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-16-E9-24869 ]]> http://thefederalregister.com/d.p/2009-10-16-E9-24869 Fri, Oct 16 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-16-E9-24871 ]]> http://thefederalregister.com/d.p/2009-10-16-E9-24871 Fri, Oct 16 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-16-E9-24877 ]]> http://thefederalregister.com/d.p/2009-10-16-E9-24877 Fri, Oct 16 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-06-E9-23974

Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Director, National Institutes of Health (NIH), announces the establishment of the Interagency Breast Cancer and Environmental Research Coordinating Committee (Committee).

The Committee shall coordinate all efforts within the Department of Health and Human Services to share and coordinate information on existing research activities, and make recommendations to the Secretary DHHS, the National Institutes of Health and other Federal agencies regarding how to improve existing research programs.

The Committee's primary mission is to facilitate the efficient and effective exchange of information on breast cancer research activities among the member agencies, and to coordinate solicitation of proposals for collaborative, multidisciplinary research, including proposals to evaluate environmental and genomic factors that may be related to the etiology of breast cancer.

Duration of this committee is two yea ]]> http://thefederalregister.com/d.p/2009-10-06-E9-23974 Tue, Oct 6 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-02-E9-23782

[[Page 50972]]

Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institute of Child Health and Human Development (NICHD), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on July 17, 2009, Volume 74, Number 136, pages 3476034761 and allowed 60days for public comment. Two public comments were received. One questioned the value of this study and suggested that the study could not possibly be completed within the stated cost estimates. We have alwa ]]> http://thefederalregister.com/d.p/2009-10-02-E9-23782 Fri, Oct 2 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-02-E9-23784

Proposed Collection: Title: Program Review of the DAIDS Policy Implementation Program Type of I ]]> http://thefederalregister.com/d.p/2009-10-02-E9-23784 Fri, Oct 2 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23601

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflicts: Visual System.

Date: October 1415, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Christine L. Melchior, PhD, Scientific Review O ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23601 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23597

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, October 12, 2009, 8 a.m. to October 13, 2009, 12 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on September 22, 2009, 74 FR 4826948273.

The meeting will be held October 13, 2009 to October 14, 2009. The meeting time and location remain the same.

The meeting is closed to the public.

Dated: September 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E923597 Filed 93009; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23597 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23600

Notice is hereby given of a change in the meeting of the Neurotransporters, Receptors, and Calcium Signaling Study Section, October 15, 2009, 8:30 a.m. to October 16, 2009, 6 p.m., Palomar Hotel, 2121 P Street, NW., Washington, DC, 20037 which was published in the Federal Register on September 22, 2009, 74 FR 4826948273.

The meeting will be one day only October 16, 2009, from 8 a.m. to 8 p.m. The meeting location remains the same. The meeting is closed to the public.

Dated: September 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E923600 Filed 93009; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23600 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23608

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Children's Study Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Children's Study Advisory Committee. [[Page 50803]]

Date: October 21, 2009.

Time: 9 a.m. to 5 p.m.

Agenda: The agenda will include a Report from the Director, NICHD, an update from the NCS Acting Director, discussions on recruitment strategies, the Vanguard Center protocol and interim outcome assessments. Additional information on the meeting logistics can be obtained on the conference Web site: ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23608 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23716

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Population Sciences Subcommittee.

Date: November 56, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: The Madison Hotel, 1177 15th St., NW., Washington, DC 20005.

Contact Person: Carla T. Walls, PhD, Scientific Review Officer, Divis ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23716 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23718

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections
[[Page 50804]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; NRSA Predoctoral Training Program in Systems Biology.

Date: October 28, 2009.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23718 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23720

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Reproduction, Andrology, and Gynecology Subcommittee.

Date: October 30, 2009.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.

Contact Person: Dennis Leszczynski, PhD, ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23720 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23723

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Function, Integration, and Rehabilitation Sciences Subcommittee.

Date: October 29, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: The Legacy, 1775 Rockville Pike, Rockville, MD 20852.

Contact Person: Anne Krey, Scientific Review Of ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23723 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23725

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Instruments and Devices for the Neonatal Intensive Care Units.

Date: November 2, 2009.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015.

Contac ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23725 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23717

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Institutional Research TrainingClinical.

Date: November 12, 2009.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC 20036.

Contact Person: Aileen Schulte, PhD, Scientific Review Officer, Division of ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23717 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-10-01-E9-23602

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDA.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute on Drug Abuse, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Board of Scientific Counselors, NIDA.

Date: November 1920, 2009.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

Place: Intramural Research Program, National Institute on Drug Abuse, NIH, John ]]> http://thefederalregister.com/d.p/2009-10-01-E9-23602 Thu, Oct 1 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-30-E9-23590 ]]> http://thefederalregister.com/d.p/2009-09-30-E9-23590 Wed, Sep 30 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-29-E9-23334

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Clinical Center, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on May 14, 2009, page 22749 and allowed 60days for public comment. One comment was received: `These meetings should be on computer software and the general population of this nation should be able to attend. This is a very cheap way to distribute information, the general public can have some understanding of what you are telling doctors to do and the open ness of the project will help all americans. It is time to stop secret meetings. They cost more for taxpayers, they don't get the message through when videotapes can be made of the information transmi ]]> http://thefederalregister.com/d.p/2009-09-29-E9-23334 Tue, Sep 29 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-29-E9-23510

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institute of Environmental Health Sciences (NIEHS), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on 10 July 2009 on page 33259 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after [[Page 49878]]
October 1, 1995, unless it displays a currently valid OMB control number.

5 CFR 1320.5: Reporting and Recordkeeping Requirements: Final Rule: Respondents to this collection of infor ]]> http://thefederalregister.com/d.p/2009-09-29-E9-23510 Tue, Sep 29 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-25-E9-23078

Proposed Collection: Title: Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research. Type of Information Collection Request: Extension, 0MB 09250601, Expiration Date 2/28/ 2010. Form Number: 2890. The form is used by applicants to request that human embryonic stem cell lines be approved for use in NIH funded research. Applicants may submit applications at any time; this request is a onetime submission. Affected Public: Business or other for profit; Notforprofit institutions; Federal Government; and State, Local or Tribal Government. Type of Respondents: Adult scientific profession ]]> http://thefederalregister.com/d.p/2009-09-25-E9-23078 Fri, Sep 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-25-E9-23265

The National Institutes of Health (NIH) announces the persons who will serve on the National Institutes of Health's Senior Executive Service 2009 Performance Review Board. This action is being taken in accordance with Title 5, U.S.C., Section 4314(c)(4), which requires that members of performance review boards be appointed in a manner to ensure consistency, stability, and objectivity in performance appraisals and requires that notice of the appointment of an individual to serve as a member be published in the Federal Register.

The following persons will serve on the NIH Performance Review Board, which oversees the evaluation of performance appraisals of NIH Senior Executive Service (SES) members: Ms. Colleen Barros (Chair); Dr. Michael Gottesman; Ms. Lenora Johnson; Ms. Robin Kawazoe; Dr. Raynard Kington; Ms. Janis Mullaney; Dr. Sally Rockey.

For further information about the NIH Performance Review Board, contact the Office of Human Resources, Workforce Relations Division, National I ]]> http://thefederalregister.com/d.p/2009-09-25-E9-23265 Fri, Sep 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-24-E9-23125 [[Page 48748]]
this study and suggested that the study could not possibly be completed within the stated cost estimates. We have always conducted extremely efficient studies within stated cost estimates. The value of this research is demonstrated by the involvement of multiple government agencies. The second email simply expressed interest in more information. The purpose of this notice is to allow an additional 30 days for p ]]> http://thefederalregister.com/d.p/2009-09-24-E9-23125 Thu, Sep 24 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-23-E9-22975 ]]> http://thefederalregister.com/d.p/2009-09-23-E9-22975 Wed, Sep 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-23-E9-22974 ]]> http://thefederalregister.com/d.p/2009-09-23-E9-22974 Wed, Sep 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-18-E9-22567

Proposed Collection: Title: Hazardous Waste Worker Training42 CFR Part 65. Type of Information Collection Request: Revision of OMB No. ]]> http://thefederalregister.com/d.p/2009-09-18-E9-22567 Fri, Sep 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-15-E9-22223 ]]> http://thefederalregister.com/d.p/2009-09-15-E9-22223 Tue, Sep 15 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-10-E9-21786 ]]> http://thefederalregister.com/d.p/2009-09-10-E9-21786 Thu, Sep 10 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-10-E9-21787 ]]> http://thefederalregister.com/d.p/2009-09-10-E9-21787 Thu, Sep 10 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-09-04-E9-21479 Proposed Collection

Title: NCCAM Customer Service Data Collection.

Type of Information Collection Request: Revision.

Need and Use of Information ]]> http://thefederalregister.com/d.p/2009-09-04-E9-21479 Fri, Sep 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-31-E9-20882

Proposed Collection: Title: Evaluation of the NIAID HIV Vaccine Research Education Initiative, Highly Impacted Population Survey. Type of Information Collection Request: NEW. Need and Use of Information Collection: Developing measures that protect against HIV infection is one of NIAID's highest priorities. Methods in development for the prevention of HIV infection include: HIV vaccines, microbicides, and preexposure prophylaxis (PrEP). Given the daunting complexity of the HIV virus, developing these methods will ultimately require tens of thousands of volunteers to participate in ]]> http://thefederalregister.com/d.p/2009-08-31-E9-20882 Mon, Aug 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-31-E9-20881 ]]> http://thefederalregister.com/d.p/2009-08-31-E9-20881 Mon, Aug 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-25-E9-20439

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Director (OD), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on June 16, 2009 (Volume 74, Number 114, pages 2850128502) and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an
[[Page 42900]]
additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

Proposed Collection: Title: NIH Intramural Research Training Program Applications. Type of Information Collect ]]> http://thefederalregister.com/d.p/2009-08-25-E9-20439 Tue, Aug 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-17-E9-19691 ]]> http://thefederalregister.com/d.p/2009-08-17-E9-19691 Mon, Aug 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-17-E9-19693 ]]> http://thefederalregister.com/d.p/2009-08-17-E9-19693 Mon, Aug 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-11-E9-19207

Proposed Collection: Title: Investigator Registration and Fina ]]> http://thefederalregister.com/d.p/2009-08-11-E9-19207 Tue, Aug 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-10-E9-19022

Proposed Collection: Title: 24hour Dietary Recall Method Compa ]]> http://thefederalregister.com/d.p/2009-08-10-E9-19022 Mon, Aug 10 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-03-E9-18496 ]]> http://thefederalregister.com/d.p/2009-08-03-E9-18496 Mon, Aug 3 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-08-03-E9-18504 ]]> http://thefederalregister.com/d.p/2009-08-03-E9-18504 Mon, Aug 3 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-29-E9-18071

Proposed Collection: Describe the proposed information collection activity as follows. Include: Title: Parental Knowledge, Attitudes, and Behaviors Related to Pediatric Cardiovascular Health; Type of Information Collection Request: New; Need and Use of Information Collection: Coinciding with the release of the Integrated Pediatric Cardiovascular Risk Reduction Guidelines, the National Heart, Lung, and Blood Institute (NHLBI) will conduct a national public awareness campaign to help parents understand that risk for cardiovascular disease (CVD) begins in childhood, and to engage them in encoura ]]> http://thefederalregister.com/d.p/2009-07-29-E9-18071 Wed, Jul 29 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-24-E9-17730

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Heart, Lung and Blood Institute (NHLBI), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on May 7, 2009, page 21372, and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

Proposed Collection: Title: NHLBI Health Information Center's Revolving Customer Satisfaction Survey. Type of Information Collection R ]]> http://thefederalregister.com/d.p/2009-07-24-E9-17730 Fri, Jul 24 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-22-E9-17319 ]]> http://thefederalregister.com/d.p/2009-07-22-E9-17319 Wed, Jul 22 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-20-E9-17214

Summary: Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Fogarty International Center (FIC) and National Institute of Environmental Health Sciences (NIEHS), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on May 12, 2009, page 22172, and allowed 60days for public comment. No comments were received from this notification regarding the cost and hour burden estimates. The purpose of this announcement is to allow an additional 30 days for public comment.

The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number.

Proposed Coll ]]> http://thefederalregister.com/d.p/2009-07-20-E9-17214 Mon, Jul 20 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17026 Proposed Collection

Title: NEXT Generation Health Study.

Type of Information Collection Request: New.

Need and Use of Information Collection:

The goal of this research is to obtain data on adolescent health and health behaviors annually for four years beginning in the 20092010 school year from a national probability sample of adolescents. This information will enable the improvement of health services and programs for youth. The study will provide needed information about the health of U.S. adolescents.

The study will collect information on adolescent health behav ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17026 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17053

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Epidemiology, Prevention Control & Population Sciences P01.

Date: October 1415, 2009.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: Hilton Washington DC/Rockville Executive Meeting C, 1750 Rockville Pike, Rockville, MD 20852.

Contact Person: Wlodek Lopaczynski ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17053 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17046

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; AIDS P01.

Date: August 12, 2009.

Time: 9 a.m. to 12:01 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6116 Executive Boulevard, Rm 8121, Rockville, MD 20852, (Telephone Conference Call)

Contact Person: Olivia Bartlett, PhD, Chief, Research Programs Rev ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17046 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17049

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Initial Review Group; Subcommittee ACancer Centers.

Date: August 7, 2009.

Time: 7:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Gail J. Bryant, MD, Scientific Review Officer, Resource ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17049 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17051

Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, July 29, 2009, 8 a.m. to July 30, 2009, 5 p.m., Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC, 20037 which was published in the Federal Register on July 8, 2009, FRE916115.

The meeting date was changed from July 2930, 2009 to July 29, 2009. The meeting is closed to the public.

Dated: July 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E917051 Filed 71609; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17051 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17085

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Antimicrobial Research and Development.

Date: August 25, 2009.

Time: 10 a.m. to 1 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call)

Contact Person: Lynn Rus ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17085 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17084

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Ancillary Studies to Major Ongoing NIDDK and NHLBI Clinical Trials PAR 07024.

Date: August 3, 2009.

Time: 1:30 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Be ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17084 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17039

Notice is hereby given of a change in the meeting of the National Institute of Environmental Health Sciences Special Emphasis Panel, July 30, 2009, 2 p.m. to July 30, 2009, 4:30 p.m., NIEHS/National Institutes of Health, Keystone Building, 530 Davis Drive, Research Triangle Park, NC 27709 which was published in the Federal Register on July 2, 2009, FR E915689.

The meeting date was changed from July 30, 2009 to August 12, 2009 and the meeting time was changed from 2 p.m. to 2:30 p.m. The meeting is closed to the public.

Dated: July 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E917039 Filed 71609; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17039 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17044

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel. ARRAStandardized Testing of Nanoparticles for Their Safety to Human Health.

Date: July 2122, 2009.

Time: 8 a.m. to 12 p.m.

Agenda: To review and evaluate grant applications.

Place: Sheraton Chapel Hill Hotel, One Europa Drive, Chapel Hill, NC 27514.

Contact Person: Sally ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17044 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17058

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Behavioral AIDS.

Date: July 22, 2009.

Time: 11 a.m. to 2:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call).

Contact Person: Enid Light, PhD, Scien ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17058 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17041

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Aging Special Emphasis Panel. ARRARC2SEP9.

Date: July 23, 2009.

Time: 1 p.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20814. (Telephone Conference Call)

Contact Person: Alicja L Markowska, PhD, DSC, Sci ]]> http://thefederalregister.com/d.p/2009-07-17-E9-17041 Fri, Jul 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-07-17-E9-17086

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Aging Special Emphasis Panel; AARARC2SEP 11.

Date: July 31, 2009.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20814, (Telephone Conference Call)

The meeting will be open to the public, however preregistration is strongly recommended due to space limitations. Persons planning to attend should register online at http://www.biosecurityboard.gov or by calling Capital Consulting Corporation (Contact: ]]> http://thefederalregister.com/d.p/2009-04-02-E9-7199 Thu, Apr 2 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7207 ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7207 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7213 ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7213 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7223 ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7223 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-6785

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Molecular Neuroscience.

Date: April 2021, 2009.

Time: 9 a.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Deborah L. Lewis, PhD, Scientific Review Officer, Ce ]]> http://thefederalregister.com/d.p/2009-03-31-E9-6785 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7226

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel Birth Defects GenomeWide Association Study.

Date: April 29, 2009.

Time: 2 p.m. to 3:30 p.m.

Agenda: To provide concept review of proposed concept review.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852. (Telephone Conference Call)

Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, 610 ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7226 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7227

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; ``The Screenable Disorders PAR''.

Date: April 30, 2009.

Time: 1 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call).

Contact Pe ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7227 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-6783

Notice is hereby given of a change in the meeting of the National Advisory Dental and Craniofacial Research Council, May 18, 2009, 8:30 a.m. to May 18, 2009, 4:30 p.m., National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD, 20892 which was published in the Federal Register on January 12, 2009, 74 FR 1222.

The meeting of the advisory council has been changed from May 18, 2009, to May 22, 2009. The meeting is partially closed to the public.

Dated: March 20, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E96783 Filed 33009; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-03-31-E9-6783 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7206

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel, ``Develop Automated Methods to Identify Environmental Exposure Patterns in Satellite Imagery Data.''

Date: April 15, 2009.

Time: 12:45 p.m. to 1:45 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, 6 ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7206 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7197

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Regulation of Cytokine
Transcription and Inflammation.

Date: March 30, 2009.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).

Contact ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7197 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-6929

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Rheumatic Disease Clinical Research Grant Review.

Date: March 31, 2009.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call ]]> http://thefederalregister.com/d.p/2009-03-31-E9-6929 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-6781

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meeting will he closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Loan Repayment.

Date: March 30, 2009.

Time: 9 a.m. to 5p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).

Contact Person: Lyle Furr, Contract Review Specialist, Office of Extram ]]> http://thefederalregister.com/d.p/2009-03-31-E9-6781 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-6787

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meeting will be closed to the public in accordance with the [[Page 14573]]
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Medication Discovery Using Rat Models of Relapse.

Date: April 14, 2009.

Time: 9 a.m. to 3 p.m.

Agenda: To review and evaluate contract proposals.

Place: Courtyard by Marriott Rockville, 2500 Research Boulevard, Rockville, MD 20850.

Contact Person: Lyle Furr, Contract Revi ]]> http://thefederalregister.com/d.p/2009-03-31-E9-6787 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7200

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Scientific Management Review Board.

The NIH Reform Act of 2006 (Pub. L. 109482) provides organizational authorities to HHS and NIH officials to: (1) Establish or abolish national research institutes; (2) reorganize the offices within the Office of the Director, NIH, including adding, removing, or transferring the functions of such offices or establishing or terminating such offices; and (3) reorganize, divisions, centers, or other administrative units within an NIH national research institute or national center including adding, removing, or transferring the functions of such units, or establishing or terminating such units. The purpose of the Scientific Management Review Board (also referred to as SMRB or Board) is to advise appropriate HHS and NIH officials on the use of these organizational authorities and identify the reasons underlying the recommen ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7200 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-31-E9-7210 ]]> http://thefederalregister.com/d.p/2009-03-31-E9-7210 Tue, Mar 31 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-30-E9-6935 ]]> http://thefederalregister.com/d.p/2009-03-30-E9-6935 Mon, Mar 30 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-30-E9-6936 ]]> http://thefederalregister.com/d.p/2009-03-30-E9-6936 Mon, Mar 30 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-30-E9-6930

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; NIH Loan Repayment Program Regarding Clinical & Pediatric Researchers.

Date: April 29, 2009.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: NIEHS/Keystone Bldg., Keystone Building, 530 Davis Drive, Research Triangle Park, NC 27709.

Contact ]]> http://thefederalregister.com/d.p/2009-03-30-E9-6930 Mon, Mar 30 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-30-E9-6934

Proposed Collection: Title: Generic Clearance to Conduct Voluntary Customer/Partner Surveys; Type of Information Collection Request: Extension of currently approved collection [OMB No. 09250476, expiration date 07/31/2009], Form Number: NA; Need and Use of Information Collection: Executive Order 12962 directed agencies that provide significant services directly to the public to survey customers to determine the kind and quality of services they want and their level of satisfaction with existing services. Additionally, since 1994, the NLM has been a ``Federal Reinvention Laboratory'' with a goal of im ]]> http://thefederalregister.com/d.p/2009-03-30-E9-6934 Mon, Mar 30 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-30-E9-6933 ]]> http://thefederalregister.com/d.p/2009-03-30-E9-6933 Mon, Mar 30 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-25-E9-6596

Notice is hereby given of a change in the meeting of the National Advisory Allergy and Infectious Diseases Council, May 18, 2009, 8:30 a.m. to May 18, 2009, 5 p.m., National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD, 20892 which was published in the Federal Register on January 14, 2009, 74 FR 2083.

The full council will meet in closed session from 12:15 p.m. to 1:15 p.m. to discuss changes in the ECB. This discussion will involve confidential material. Subcommittee meetings that were to start at 1 p.m. will begin at 1:30 p.m. The meeting is partially closed to the public.

Dated: March 19, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E96596 Filed 32409; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-03-25-E9-6596 Wed, Mar 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-25-E9-6599

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Research Resources Council.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion ]]> http://thefederalregister.com/d.p/2009-03-25-E9-6599 Wed, Mar 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-25-E9-6591 [[Page 12875]]
projects to be submitted to the Office of Management and Budget (OMB) for review and approval. ]]> http://thefederalregister.com/d.p/2009-03-25-E9-6591 Wed, Mar 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6481

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; BDCN Member Conflict.

Date: April 79, 2009.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Pat Manos, PhD, Scientific Review Officer, Center for Scien ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6481 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6343

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; MultiDrug Combinations to Promote Neurological Recovery in Traumatic Brain Injury.

Date: April 16, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Ramada Inn Rockville, 1775 Rockville Pike, Rockville, MD 20852.

Contact Pers ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6343 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6198 ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6198 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6339

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2); notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; ``Improved Effectiveness of Smoking Cessation Interventions and Programs in Low Income Adult Populations''.

Date: April 23, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Marriott Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersbur ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6339 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6205

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Sleep Disorders Research Advisory Board.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Sleep Disorders Research Advisory Board.

Date: April 14, 2009.

Time: 12 p.m. to 4:30 p.m.

Agenda: To discuss sleep research, education priorities, and programs.

Place: National Institutes of Health, Building 45, 45 Center Drive, Natcher Auditorium, Bethesda, MD 20892.

Contact Person: Michael J Twery, PhD, Director, National Center on Sleep Disorders Research, Division of Lung Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Sui ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6205 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6207

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Conference Grants (R13's).

Date: March 31April 1, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: David A Wilson, PhD, Scientific Re ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6207 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6204

Pursuant to section 10(d) of the Federal Advisory Committee Act, as [[Page 12142]]
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Water Balance.

Date: April 10, 2009.

Time: 3 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6204 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6199

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Allergy and Infectious Diseases Council.

The meeting will be open to the public. Individuals who wish to listen to the meeting should register with Jemma Long at the phone number of the contact person listed below at least two days in advance of the meeting.

Name of Committee: National Advisory Allergy and Infectious Diseases Council; Allergy, Immunology and Transplantation
Subcommittee.

Date: March 31, 2009.

Time: 1 p.m. to 1:30 p.m.

Agenda: The subcommittee will be discussing a concept clearance for the Human Immunology Profiling Centers of Excellence (U01/U19).

Place: National Institutes of Health, 6610 Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).

Contact Person: Daniel Rotrosen, PhD, Director, Division of Allergy, Immunology & Transplantation, National Institutes of Health/NIAID, 6610 ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6199 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6200

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Highly Innovative Technologies to Interrupt Transmission of HIV.

Date: April 2324, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910.

Contact Person: Clayton C ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6200 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6203

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Lupus Program Project.

Date: April 7, 2009.

Time: 12 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Room 3146, Bethesda, MD 20817 (Telephone Conference Call).

Contact Person: Kenneth E ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6203 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6201

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, National Institute of Dental and Craniofacial Research.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Dental & Craniofacial Research, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Board of Scientific Counselors, National Institute of Dental and Craniofacial Research.

Date: June 79, 2009.

Time: June 7, 2009, 7 p.m. to 8:30 p.m.

Agenda: To review and evaluate personal qualifications and perfo ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6201 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6206

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review Extramural Loan Repayment Applications.

Date: April 29, 2009.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
]]> http://thefederalregister.com/d.p/2009-03-23-E9-6206 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-23-E9-6202

Notice is hereby given of a change for the meeting of the Services Subcommittee of the Interagency Autism Coordinating Committee (IACC), March 26, 2009, 1 p.m. to 5 p.m. Eastern Time at the Hubert H. Humphrey Building, Conference Room 335G2, 200 Independence Avenue, SW., Washington, DC, 20201which was published in the Federal Register on March 9, 2009, 74FR10060.

The Webinar Link for Registration and Access Information that was listed in the notice has been changed. The correct Webinar link is https://www1.gotomeeting.com/register/892570174. To access the conference call the Dialin number is 8884552920 and the Access code is 3857872. The time remains the same.

Dated: March 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E96202 Filed 32009; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-03-23-E9-6202 Mon, Mar 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-5970

Notice is hereby given of a change in the meeting of the Subcommittee for Planning the Annual Strategic Plan Updating Process of the Interagency Autism Coordinating Committee (IACC), March 17, 2009, 12 p.m. to 3 p.m. Eastern Time at the National Institutes of Health, 31 Center Drive, Building 31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892 which was published in the Federal Register on March 9, 2009, 74 FR 10059.

The meeting location has been changed. The meeting will be held in the Neuroscience Building, 6001 Executive Boulevard, Conference Room A, Rockville, MD 20852. The time remains the same. The meeting will be open to the public with attendance limited to space available. The meeting will also be open to the public through a conference call phone number (Dial: 8884552920 and Access code: 3857872).

Dated: March 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E95970 Filed 31809; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-03-19-E9-5970 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6024

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel. Training Special Emphasis Panel.

Date: April 2, 2009.

Time: 12 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call).
]]> http://thefederalregister.com/d.p/2009-03-19-E9-6024 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6046

Notice is hereby given of a change in the meeting of the President's Cancer Panel, March 17, 2009, 1 p.m. to 3 p.m. which was published in the Federal Register on February 25, 2009, 74 FR 8557.

This meeting is being amended to reschedule the meeting to Monday, March 23, 2009, 12:30 p.m. to 3 p.m. as a telephone conference. The meeting is closed to the public.

Dated: March 13, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E96046 Filed 31809; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6046 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6037

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on June 26, 2008, (Vol. 73 No. 124, page 36337) and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after November 15, 2008, unless it displays a currently valid OMB control number.

Proposed Collection: Title: Simulations for Drug Related Science Education. Type of Information Collection Request: NEW. N ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6037 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6052

Proposed Collection: Title: Survey of NHLBI Constituents' Health Information Needs and Preferred Formats. Type of Information Collection Request: NEW. Need and Use of Information Collection: The purpose of this survey is to obtain information from NHLBI constituents (health professionals, patients and their families, and the general public) for the purpose of evaluating their health information and education needs and format preferences. The Consumer Services Team (CST) will use the data collected in this survey to create a 3year Strategic Plan. The findings from the survey, described in the S ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6052 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6028

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel. CB IRG Member SEP.

Date: March 24, 2009.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call).

Contact Person: Jonathan Arias, PhD, Scientific Review Officer, Ce ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6028 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6043

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Cancer Therapeutics.

Date: April 2, 2009.

Time: 9 a.m. to 10:30 a.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call)

Contact Person: Syed M. Quadri, PhD, Scientific Review Office ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6043 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-5972

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel. Translational Analyses of Chronic Aberrant Behavior Across the Life Span.

Date: March 30, 2009.

Time: 1 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute of Child Health and Human Development, 6100 Executive Boulevard, Ro ]]> http://thefederalregister.com/d.p/2009-03-19-E9-5972 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6048

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Therapeutic Strategies to Augment Muscle Rehabilitation.

Date: April 17, 2009.

Time: 1:30 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone Conf ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6048 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6050

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; The Cognitive, Social and Cultural Bases of Early Physical Science Learning.

Date: April 7, 2009.

Time: 1 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute of Child Health and Human Development, 6100 Executive Blvd., Room ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6050 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6036

Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Council for Complementary and Alternative Medicine (NACCAM) meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussion could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Advisory Council for Complementary and Alternative Medicine.

Date: April 7, 2009.

Closed: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications and/or proposals.

Place: National Institutes of Health, 6707 ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6036 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6045

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council on Aging.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Advisory C ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6045 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-5975

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation (U01) and Planning (R34) Grants.

Date: April 8, 2009.

Time: 11 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Ca ]]> http://thefederalregister.com/d.p/2009-03-19-E9-5975 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-5967

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel. Insulin Resistance Mentored Awards.

Date: April 2, 2009.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. (Telephone Conferenc ]]> http://thefederalregister.com/d.p/2009-03-19-E9-5967 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-19-E9-6051

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, MBRS Grant Applications.

Date: March 31, 2009.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Natcher Building, Room 3AN12, 45 Center Drive, Bethesda, MD 20852 (Telephone Conference Call).

Contact Person: ]]> http://thefederalregister.com/d.p/2009-03-19-E9-6051 Thu, Mar 19 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-13-E9-5521

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of the Director, the National Heart, Lung, and Blood Institute (NHLBI), the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection
[[Page 10945]]
listed below. This proposed information collection was previously published in the Federal Register on December 30, 2008, page 79889 79890 and allowed 60days for public comment. One comment was received and appropriate response was made. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised or implemented on or after October 1, 1995 unless it displays a current valid OMB control number.

Proposed Collection: Title: Women's Health Initiative (WHI) ]]> http://thefederalregister.com/d.p/2009-03-13-E9-5521 Fri, Mar 13 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-13-E9-5418 ]]> http://thefederalregister.com/d.p/2009-03-13-E9-5418 Fri, Mar 13 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-12-E9-4991

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel. Genes, Genetics, Genomics.

Date: March 2324, 2009.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Mary P. McCormick, PhD, Scientific Review O ]]> http://thefederalregister.com/d.p/2009-03-12-E9-4991 Thu, Mar 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-12-E9-5316

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Unsolicited P01 Application.

Date: March 31, 2009.

Time: 9 a.m. to 11:30 a.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).

Contact Person: Eleazar Cohe ]]> http://thefederalregister.com/d.p/2009-03-12-E9-5316 Thu, Mar 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-12-E9-5314

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Digestive Diseases and Nutrition F32 Review.

Date: March 19, 2009.

Time: 2:30 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone ]]> http://thefederalregister.com/d.p/2009-03-12-E9-5314 Thu, Mar 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-12-E9-5317

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Sexual Dysfunction and LUTS Ancillary Studies.

Date: March 31, 2009.

Time: 3:30 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Teleph ]]> http://thefederalregister.com/d.p/2009-03-12-E9-5317 Thu, Mar 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-12-E9-4989

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences, Special Emphasis Panel Sites and Mechanisms of Inhaled Anesthetic Actions.

Date: March 27, 2009.

Time: 11 a.m. to 3:30 p.m.

[[Page 10749]]

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Natcher Building, Room 3AN18, 45 Center Drive, Bethesda, MD 20892 (Tele ]]> http://thefederalregister.com/d.p/2009-03-12-E9-4989 Thu, Mar 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-11-E9-5133

Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on December 10, 2008, page 75121 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after November 30, 2010, unless it displays a currently valid OMB control number.

Proposed Collection: Title: Research and Research Training Grant Applications and Related Forms. Type of Information Collection Request: Revision, OMB 09250001, Expiration Date 11/30/ ]]> http://thefederalregister.com/d.p/2009-03-11-E9-5133 Wed, Mar 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-09-E9-4836

Proposed Collection

Title: REDSII Donor Iron Status Evaluation (RISE) Study. Type of Information Collection Request: Revision of a currently approved collection. OMB control 09250581. Expiration Date: 05/31/ 2009. Need and Use of Information Collection: Although the overall health significance of iron depletion in blood donors is uncertain, iron depletion leading to iron deficient erythropoiesis and lowered hemoglobin levels results in donor deferral and, occasionally, in mild iron deficiency anemia. Hemoglobin deferrals represent more than half of all donor deferral, deferring 16% of women. The RIS ]]> http://thefederalregister.com/d.p/2009-03-09-E9-4836 Mon, Mar 9 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4416

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel; Special: Biomaterials and Biointerfaces.

Date: March 9, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Ross D. Shonat, PhD, Scienti ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4416 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4617

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; ``Aging in Down Syndrome Adults''.

Date: April 1, 2009.

Time: 11 a.m. to 1 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call).

Cont ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4617 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4615

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIAMS.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual other conducted by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Board of Scientific Counselors, NIAMS.

Date: March 1617, 2009.

Time: 5:30 p.m. to 6 p.m.

Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

Place: National Institutes of Health, Building 31, 31 Center Dri ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4615 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4616

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Diabetes and Digestive and Kidney Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Board of Scientific Counselors, NIDDK.

Date: April 2930, 2009.

Time: April 29, 2009, 8:30 a.m. to 4:15 p.m.

Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

Place: National Institut ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4616 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4619

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2) notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The purpose of this meeting is to evaluate requests for preclinical development resources for potential new therapeutics for type 1 diabetes. The outcome of the evaluation will be a decision whether NIDDK should support the request and make available contract resources for development of the potential therapeutic to improve the treatment or prevent the development of type 1 diabetes and its complications. The research proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the proposed research projects, the disclosure of which would constitute a clearly unwarrant ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4619 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4623

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; KApplication SEP.

Date: March 26, 2009.

Time: 12 p.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

Con ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4623 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4629

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Urothelium and UTI Program Projects.

Date: March 27, 2009.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.

Contact Person: Lakshmanan Sankaran, ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4629 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4630

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Center for AIDS Intervention Research Core Support.

Date: March 27, 2009.

Time: 11 a.m. to 2 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).
]]> http://thefederalregister.com/d.p/2009-03-04-E9-4630 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-04-E9-4618 [[Page 9412]]
entitled ``Addressing Biosecurity Concerns Related to the Synthesis of Select Agents.'' \1\ The report included a recommendation that the United States Government (USG) ``examine the language and
implementation of current biosafety guidelines to ensure that such guidelines and regulations provide adequate guidance for working with synthetically derived DNA and are understood by all those working in areas addressed by the guidelines.'' The USG adopted this
recommendation and asked NIH to review the NIH Guidelines for Research with Recombinant DNA (NIH Guidelines) to evaluate whether these guidelines need to be revised to address biosafety concerns for research with synthetic DNA. With the advice of the NIH Recombinant DNA Advisory C ]]> http://thefederalregister.com/d.p/2009-03-04-E9-4618 Wed, Mar 4 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-03-03-E9-4477 ]]> http://thefederalregister.com/d.p/2009-03-03-E9-4477 Tue, Mar 3 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-27-E9-4209

Proposed Collection: Title: Ruth L. Kirschstein NRSA Individual Fellowship Application and Related Forms. Type of Information Collection Request: Revision, OMB 09250002, Expiration Date 9/30/11. Form Numbers: PHS 4161, 4169, 4165, 4167, 6031, 60311.

Need and Use of Information Collection: The PHS 4161and 4169 are used by individuals to apply for direct research training support. Awards are made to individual applicants for specified training proposals in biomedical and behavioral research, selected as a result of a national competition. The other related forms (PHS 4165, 4167, 6031, 60311) are used by these ]]> http://thefederalregister.com/d.p/2009-02-27-E9-4209 Fri, Feb 27 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-25-E9-4047

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Developmental mechanisms of human structural birth control.

Date: March 26, 2009.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone Conf ]]> http://thefederalregister.com/d.p/2009-02-25-E9-4047 Wed, Feb 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-25-E9-4052

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Program Project in Vascular Disease.

Date: March 17, 2009.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Shelley S Sehnert, ]]> http://thefederalregister.com/d.p/2009-02-25-E9-4052 Wed, Feb 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-25-E9-4046

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel, Conference Grants with an Environmental Health Focus.

Date: March 30, 2009.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, Research Triangle Park, N ]]> http://thefederalregister.com/d.p/2009-02-25-E9-4046 Wed, Feb 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-25-E9-4048

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President's Cancer Panel.

The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended, because the premature disclosure of these discussions would be likely to significantly frustrate implementation of recommendations.

Name of Committee: President's Cancer Panel.

Date: March 17, 2009.
[[Page 8558]]

Time: 1 p.m. to 3 p.m.

Agenda: Review and evaluate the final draft for the Environmental Factors in Cancer 2008/2009 Annual Report.

Place: National Cancer Institute, Office of the Director, National Institutes of Health, 6116 Executive Blvd., Suite 220, Bethesda, MD 20892 (Teleconference).

Contact Person: Abby Sandler, PhD., Executive Secretary, Chief, Institute Review Office, Office of the Director, National Cancer Institute, NIH, 6116 Executive Blvd., S ]]> http://thefederalregister.com/d.p/2009-02-25-E9-4048 Wed, Feb 25 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-24-E9-3952

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group; Obstetrics and MaternalFetal Biology Subcommittee.

Date: March 23, 2009.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications and/or proposals.

Place: Courtyard Gaithersburg Washingtonian Center, 204 Boardwalk Place, Gaithersburg, MD 20878.

Co ]]> http://thefederalregister.com/d.p/2009-02-24-E9-3952 Tue, Feb 24 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-24-E9-3956

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group. Population Sciences Subcommittee.

Date: March 2627, 2009.

Time: 8 a.m to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: The Madison Hotel, 1177 15th Street, NW., Washington, DC 20005.

Contact Person: Carla T. Walls, PhD, Scientific Review Adminis ]]> http://thefederalregister.com/d.p/2009-02-24-E9-3956 Tue, Feb 24 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-24-E9-3950

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Training Grant Applications.

Date: March 20, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Natcher Building, Room 3AN12, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Per ]]> http://thefederalregister.com/d.p/2009-02-24-E9-3950 Tue, Feb 24 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-24-E9-3844

Notice is hereby given that I have delegated to the Director, National Institutes of Health (NIH), with the authority to redelegate, the authorities under Section 105 of the National Institutes of Health Reform Act of 2006 (Pub. L. No. 109482), 42 U.S.C. 284n, pertaining to certain demonstration projects authorized by this Section.

The Secretary of Health and Human Services retains the authority to submit reports to Congress. The delegation shall be exercised in accordance with the Department's applicable policies, procedures, guidelines and regulations. In addition, the delegation ratifies and affirms any actions taken by the Director, National Institutes of Health, or subordinates that involved the exercise of the authorities prior to the effective date of the delegation.

This delegation is effective upon date of signature.

Dated: February 9, 2009.
Charles E. Johnson,
Acting Secretary.
[FR Doc. E93844 Filed 22309; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-02-24-E9-3844 Tue, Feb 24 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-23-E9-3811 ]]> http://thefederalregister.com/d.p/2009-02-23-E9-3811 Mon, Feb 23 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-20-E9-3584

Proposed Collection: Title: A Process Evaluation of the NIH Director's New Innovator Award (NIA) Program. Type of Information Collection Request: New collection. Need and Use of Information Collection: This study will assess the NIA Program operations and the outputs of the identification, evaluation and selection process. The primary objectives of the study are to: (1) Assess the NIA award selection process; (2) determine if the program was implemented as planned; and (3) determine if the process was conducted in accordance with the overall mission of the NIA program. The findings will provide valuable information c ]]> http://thefederalregister.com/d.p/2009-02-20-E9-3584 Fri, Feb 20 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3317

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning
[[Page 7618]]
individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Aging Special Emphasis Panel, Anemia.

Date: March 10, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway, 7201 Wisconsin Ave., 2C212, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Alicja L Markowska, PhD, DSC, Scientific Revi ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3317 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3442

The National Institutes of Health (NIH) Public Access Policy requires investigators funded by the NIH to submit, or have submitted for them, an electronic version of their final, peerreviewed manuscripts upon acceptance for publication to the National Library of Medicine's digital archive, PubMed Central, to be posted publicly within 12 months after the official date of publication. Congress required the NIH to implement this funding limitation in Division G, Title II, Section 218 of the Consolidated Appropriations Act of 2008 (``Section 218''). The Policy is intended to advance science, provide public access to the published results of NIHfunded research, and improve human health.

The current Public Access Policy is the culmination of years of effort and community interaction. Prior to passage of Section 218, the NIH undertook extraordinary public outreach concerning the issue of public access to the published results of NIHfunded research. These outreach efforts included a review of over ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3442 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3300

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Center for Scientific Review Special Emphasis Panel, ELSI Microbiome.

Date: February 27, 2009.

Time: 1:30 p.m. to 6:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Richard A. Currie, Ph.D., Scientific Review Officer, ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3300 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3304

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 2, 2009, 12 p.m. to February 2, 2009, 1 p.m., Mayflower Park Hotel, 405 Olive Way, Seattle, WA, 98101 which was published in the Federal Register on January 16, 2009, 74 FR 30643065.

The meeting will be held February 27, 2009, from 2 p.m. to 4 p.m. The meeting location remains the same. The meeting is closed to the public.

Dated: February 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93304 Filed 21709; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3304 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3305

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 24, 2009, 11 a.m. to February 25, 2009, 12 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on February 5, 2009, 74 FR 61666169.

The meeting title has been changed to ``Brain Injury Member SEP''. The meeting is closed to the public.

Dated: February 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93305 Filed 21709; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3305 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3313

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel, R13 Conference Grant Review.

Date: March 19, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6116 Executive Boulevard, Room 8041, Rockville, MD 20852. (Telephone Conference Call)

C ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3313 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3435

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Center for Research Resources Special Emphasis Panel; Research Web Portal.

Date: March 19, 2009.

Time: 11 a.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Guo Zhang, MD, PhD, S ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3435 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3430

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Ancillary Studies in
Immunomodulation Clinical Trails.

Date: March 13, 2009.

Time: 2 p.m. to 4:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).

Contact Pers ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3430 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3420

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Population Research
Infrastructure Program.

Date: March 13, 2009.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications and/or proposals.

Place: Rennaissance Mayflower Hotel, 1127 Connecticut Avenue NW., Washington, DC.

Contact Person: Marita R. Hopmann, ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3420 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3421

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review U13, Conference Cooperative Agreement.

Date: April 15, 2009.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6706 Democracy Blvd., Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Mary Kel ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3421 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3312

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH R34 AIDS Application Review.

Date: March 13, 2009.

Time: 11 a.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health NIMH, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Enid Li ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3312 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3314

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel; Mental Disorders.

Date: March 18, 2009.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Francois Boller, MD, PhD, Sci ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3314 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-18-E9-3306

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders B.

Date: February 2627, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: The Catamaran Resort Hotel Spa, 3999 Mission Boulevard, San Diego, CA 92109.

Contact Person: Ernest W Lyons, PhD, Scientific Re ]]> http://thefederalregister.com/d.p/2009-02-18-E9-3306 Wed, Feb 18 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3198

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Center for Complementary and Alternative
[[Page 7453]]
Medicine Special Emphasis Panel; Fellowships.

Date: March 2425, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard,Bethesda, MD 20892,(Virtual Meeting).

Contact Person: Peter Ko ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3198 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3191

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Human Genome Research Institute Special Emphasis Panel; Community Consultation.

Date: March 16, 2009.

Time: 2:30 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 5635 Fishers Lane, NHGRI Twinbrook Library,Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Rudy O. Pozzatti, ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3191 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3193

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, Innate Immune Receptors & Adjuvant Discovery.

Date: March 1617, 2009.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate contract proposals.

Place: Crowne Plaza HotelSilver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910.

Contact Person: Paul A. Amstad, PhD, Scientifi ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3193 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3205

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Program Project Review.

Date: March 19, 2009.

Time: 11 a.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call).

Conta ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3205 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3196

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Smooth Muscle in Diabetes Program Projects.

Date: March 26, 2009.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.

Contact Person: Carol J. GoterRobinson, PhD, S ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3196 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3197

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special EmphasisPanel; Implementation Planning Grants for Educational, Behavioral, or Social Studies for
Translation of Genetic Factors in Common Diseases (U34).

Date: March 11, 2009.

Time: 4 p.m. to 7 p.m.

Agenda: To review and evaluate grant applications.

Place: Courtyard Marriott, 204 Bo ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3197 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3190

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory General Medical Sciences Council.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Advisory General Medical Sciences Council.

Date: March 4, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Natcher Building, Room 2AS10, 45 Center Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Ann A. Haga ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3190 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3310

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel; Clinical Trials.

Date: March 12, 2009.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6130 Executive Blvd., Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Christine A. Livingsto ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3310 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3307

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDCD.

[[Page 7455]]

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute on Deafness and Other Communication Disorders, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Board of Scientific Counselors, NIDCD.

Date: March 27, 2009.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators.

Place: National Institutes of Health, 5 Rese ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3307 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3192

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Limited Competition for Data Sharing for Demographic Research Infrastructure.
[[Page 7451]]

Date: March 2, 2009.

Time: 3 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 2 ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3192 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3195

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Time Perception and Timed Performance in Autism.

Date: March 10, 2009.

Time: 12 p.m. to 1 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call).

Co ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3195 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3212

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Chondrocyte Maturation and Chondrodysplasias.

Date: March 11, 2009.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone Conference Call).

Contact ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3212 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3200

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 16, 2009, 8 a.m. to March 17, 2009, 6 pm, Hilton Washington DC North/Gaithersburg, 620 Perry Parkway, Gaithersburg, MD, 20877 which was published in the Federal Register on December 17, 2008, 73 FR76669.

This notice is amended to change the date from March 1617, 2009 to March 1011, 2009, 6 pm. The meeting is closed to the public.

Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93200 Filed 21309; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3200 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3201

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 26, 2009, 8:30 a.m. to March 26, 2009, 6 p.m., Bethesda MarriottPooks Hill, 5151 Pooks Hill Road, Bethesda, MD 20814 which was published in the Federal Register on January 12, 2009, 74 FR71219.

This notice is amended to change the Scientific Review Officer from Rhonda J. Moore, PhD to Gerald Lovinger, PhD. The meeting is closed to the public.

Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93201 Filed 21309; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3201 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3202

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 12, 2009, 8:30 a.m. to March 13, 2009, 5 p.m., Bethesda MarriottPooks Hill, 5151 Pooks Hill Road, Bethesda, MD, 20814 which was published in the Federal Register on January 12, 2009, 74 FR71219.

This notice is amended to change the Scientific Review Officer from Rhonda J. Moore, PhD to Joyce C. Pegues, PhD. The meeting is closed to the public.

Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93202 Filed 21309; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3202 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3211

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Molecular Pharmacodynamic Assays for Targeted Therapies.

Date: March 19, 2009.

Time: 10:30 a.m. to 1:30 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, 6116 Executive Boulevard, Conference Room 611, Rockville, MD 20852, (Telephone Conference Cal ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3211 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3237

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 3, 2009, 9 a.m. to March 3, 2009, 2 p.m., National Institutes of Health, 6116 Executive Blvd., Rockville, MD 20852 which was published in the Federal Register on January 12, 2009, 74 FR 71219.

This notice is amended to change the Scientific Review Officer from Rhonda J. Moore, PhD to Marvin L. Salin, PhD. The meeting is closed to the public.

Dated: February 9, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93237 Filed 21309; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3237 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3308

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 24, 2009, 8 a.m. to March 24, 2009, 5 p.m., Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD, 20877 which was published in the Federal Register on January 29, 2009, 74FR5171.

The meeting notice is changed to reflect the date change from March 24, 2009 to April 2, 2009. The meeting is closed to the public.

Dated: February 10, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93308 Filed 21309; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3308 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-17-E9-3309

Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 11, 2009, 8 a.m. to March 12, 2009, 6 p.m., National Cancer Institute/NIH, 6116 Executive Blvd., Room 8053, Rockville, MD 20852 which was published in the Federal Register on January 29, 2009, 74FR5170.

The meeting notice is changed to reflect the date change from March 1112, 2009 to March 1819, 2009. The meeting is closed to the public.

Dated: February 11, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E93309 Filed 21309; 8:45 am]
BILLING CODE 414001P ]]> http://thefederalregister.com/d.p/2009-02-17-E9-3309 Tue, Feb 17 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2940

Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group, Reproduction, Andrology, and Gynecology Subcommittee.

Date: March 9, 2009.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant applications.

Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814.

Contact Pers ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2940 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2942

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Child Health and Human Development Initial Review Group, Pediatrics Subcommittee.

Date: March 1920, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: The Legacy Hotel, 1775 Rockville Pike, Rockville, MD 20852.

Contact Person: Rita Anand, PhD, Scientific Review Administrator, Division ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2942 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2955

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Cancer Institute Director's Consumer Liaison Group.

Date: March 2627, 2009.

Time: March 26, 2009, 8:30 a.m. to 4 p.m.

Agenda: (1) Approval of Minutes and Welcome; (2) Office of Advocacy Relations Update; (3) Advocates in Research Working Group Update and Discussion; (4) PCP Update and Discussion; (5) Approaches to
[[Page 7069]]

Engaging Advocates in Translational Research.

Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San Jacinto at 8th Street, Lo ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2955 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2953

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Bioassays Using Pluripotent Stem Cells.

Date: March 2, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Robert Blaine Mo ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2953 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2959

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; SBIR Topic 45Iron Chelators to Treat Iron Overload.

Date: March 3, 2009.

Time: 1 p.m. to 4 p.m.

Agenda: To review and evaluate contract proposals.

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).

Contact Person: Wil ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2959 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2938

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Review of Immunology, Allergy & Asthma Training Grant Applications.

Date: March 26, 2009.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2938 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2840

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, Translation of Common Disease Genetics into Clinical Applications (R21).

Date: March 1112, 2009.

Time: 7 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: Washingtonian Center Courtyard, 204 Boardwalk Place, Gaithersburg, MD 20878.
]]> http://thefederalregister.com/d.p/2009-02-12-E9-2840 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2934

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; ZGM1 MORE1 BB.

Date: March 9, 2009.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Helen R. Sunshine, PhD, Chief, Office of Scientific Review, Natio ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2934 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2943

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of General Medical Sciences Initial Review Group; Biomedical Research and Research Training Review Subcommittee A.

Date: March 5, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Double Tree Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Carole H. Latker, PhD, Sci ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2943 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2956

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Mental Health Special Emphasis Panel, PTSD Risk Assessment Tools.

Date: March 9, 2009.

Time: 12 p.m. to 4 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call).

Contact Person: Serena ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2956 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-12-E9-2939

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Recombinant DNA Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Recombinant DNA Advisory Committee.

Date: March 34, 2009.

Time: March 3, 2009, 8:30 a.m. to 5:30 p.m.

Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols as well as related data management activities. The meeting also includes a new protocol for XSCID. Please check the meeting agenda at http:// www4.od.ni ]]> http://thefederalregister.com/d.p/2009-02-12-E9-2939 Thu, Feb 12 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-11-E9-2820 ]]> http://thefederalregister.com/d.p/2009-02-11-E9-2820 Wed, Feb 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-11-E9-2821 ]]> http://thefederalregister.com/d.p/2009-02-11-E9-2821 Wed, Feb 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-11-E9-2822 ]]> http://thefederalregister.com/d.p/2009-02-11-E9-2822 Wed, Feb 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-11-E9-2829

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

Place: https://www1.gotomeeting.com/register/287708090

Conference Call: Dial: (888) ]]> http://thefederalregister.com/d.p/2009-02-11-E9-2826 Wed, Feb 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-11-E9-2844

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Aging Special Emphasis Panel, ASPRIN TRIAL.

Date: March 2, 2009.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institutes of Health, Gateway Building, 7201 Wisconsin Ave., Suite 2C212, Bethesda, MD 20892. (Telephone Conference Call)

Contact Person: Ramesh Vemuri, PhD, Chief, Scientific ]]> http://thefederalregister.com/d.p/2009-02-11-E9-2844 Wed, Feb 11 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-10-E9-2599

Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 12, 2009, 3 p.m. to February 12, 2009, 5 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on January 30, 2009, 74 FR 5661.

The meeting will be held February 23, 2009, from 4 p.m. to 5:30 p.m. The meeting location remains the same.

The meeting is closed to the public.

Dated: February 2, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E92599 Filed 2909; 8:45 am]
BILLING CODE 414001M ]]> http://thefederalregister.com/d.p/2009-02-10-E9-2599 Tue, Feb 10 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-03-E9-2269

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other
[[Page 5938]]
reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Diabetes a ]]> http://thefederalregister.com/d.p/2009-02-03-E9-2269 Tue, Feb 3 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-03-E9-2275

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute on Aging Special Emphasis Panel, ITP Review Meeting.

Date: February 23, 2009.

Time: 2 p.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Room 2C212, Bethesda, MD 20814. (Telephone Conference Call)

Contact Person: Bita Nakhai, PhD, ]]> http://thefederalregister.com/d.p/2009-02-03-E9-2275 Tue, Feb 3 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-02-02-E9-1970

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Oncological Sciences Integrated Review Group, Drug Discovery and Molecular Pharmacology Study Section.

Date: February 910, 2009.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant applications.

Place: Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314.

Contact Person: Hungyi Shau, PhD, Scientific Review Officer, Ce ]]> http://thefederalregister.com/d.p/2009-02-02-E9-1970 Mon, Feb 2 2009 11:00:00 GMT http://thefederalregister.com/d.p/2009-01-22-E9-1162

Notice is hereby given of the National Institutes of Health (NIH) Office of Dietary Supplements (ODS) Analytical Methods and Reference Materials Program, Dietary Supplement Element Methodology Workshop to be held Monday, March 23rd and Tuesday, March 24th, 2009 at the Marriott Gaithersburg Washingtonian Center Hotel in Gaithersburg, Maryland, 20878.

Summary: Late in 2001, the U.S. Congress addressed the need for support of analytical methods and reference materials development related to dietary supplements. The Congressional appropriation language supported an increased ODS budget for several topics, including analytical methods and reference materials. The Senate language called for: ``ODS to allocate sufficient funds to speed up an ongoing collaborative effort to develop and disseminate validated analytical methods and reference materials for the most commonly used botanicals and other dietary supplements.''

On February 8, 2002, ODS held a public meeting to solicit comments to as